Measuring Cannabis Impairment Through Smart Phone Tool
Click here to Complete Eligibility Questionnaire A New smart-Phone Impairment Measurement Tool Study In Recent studies, it has been reported that nearly half of North American Adults use cannabis on a regular basis. Like alcohol, the use of cannabis is legal, but there is concern about workplace safety and use on the job. Since […]
Major Depression Disorder and Psilocybin For Health Care Workers
Although the pandemic has posed challenges for everyone, frontline healthcare workers have faced unique struggles and are experiencing significantly increased stress due to their jobs. Factors like higher workloads, hazardous conditions, and stigmatization have led to greater mental health concerns than pre-COVID-19 levels. Previous bio-disasters, including SARS, MERS, and Ebola, demonstrate that the mental health […]
New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid
Read the article New Study Shows Vitamin C With Metabolites Reduces Oxalate Levels Compared To Ascorbic Acid using the link below: https://www.suna.org/download/members/unjarticles/2009/09apr/95.pdf
KGK Science Joins the Natural Products Association as a New Board Member
The Time is Right for Us to Be a Leader at the Table in Those Board Discussions” London, ON – As part of the growth and outreach in the natural product space on a wide range of issues, including their lead on cannabidiol, KGK Science announced today that it has joined the Board of the […]
KGK Science Applauds the Efforts of Congress to Begin Removing Regulatory Hurdles for CBD
KGK SCIENCE APPLAUDS THE EFFORTS OF CONGRESS TO BEGIN REMOVING REGULATORY HURDLES FOR CBD KGK Science, the leader in providing human clinical trials and regulatory support for the U.S. dietary supplement and nutraceutical industry and recent NPA board member, applauds the efforts of Congress to begin removing regulatory hurdles, creating a pathway to market for CBD […]
KGK Science Secures Cannabis Research License for a Clinical Trial Sponsored by New Age Nanotech
LONDON, ON (September 10, 2019) – KGK Science Inc. (“KGK”), a subsidiary of Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly”), has been issued a Cannabis Research License by the Licensing and Medical Access Directorate of Health Canada, Controlled Substances and Cannabis Branch, allowing the company to possess and administer cannabis for a Phase I human […]
KGK Science Grows with the Addition of Dr. Corey Hilmas as Chief Regulatory Officer
LONDON, ON (October 2019) – KGK Science Inc. (“KGK”) is a different company than it was in 2018. Following their acquisition by Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly”), KGK has seen significant growth as a leading contract research organization in the nutraceutical and cannabinoid industries. A testament to this growth is the addition of Dr. Corey […]
KGK Science CEO Joins Natural Products Canada Board of Directors
KGK Science announced the appointment of its President and CEO, Najla Guthrie, to the Board of Directors for Natural Products Canada (NPC). As a leader in the field of nutritional science, Guthrie has over 23 years of experience advocating for the natural health products industry, specifically for the responsible change to the way health claims are […]
KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device
KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device KGK Science has been contracted by the Hamilton, Ontario-based neurotech firm, Zentrela Inc. to conduct a phase II clinical trial to prove the accuracy of their cannabis impairment test, the Cognalyzer™. Previously tested in a feasibility study supported by the Ontario Government, the Cognalyzer™ demonstrated […]
KGK Science Clinic Measures During COVID-19
As the status of the COVID-19 pandemic continues to evolve, KGK Science remains committed to the health and safety of our clinical trial participants and KGK employees. We continue to assess risks as new information becomes available. Additionally, we are adapting practices as advised by government health officials and the province of Ontario. Therefore, we […]